Followers | 702 |
Posts | 27451 |
Boards Moderated | 3 |
Alias Born | 07/03/2003 |
Sunday, July 27, 2014 11:35:54 PM
basic chart ## source: stockcharts.com
basic chart ## source: eoddata.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$VPRO DD Notes ~ http://www.ddnotesmaker.com/VPRO
$VPRO recent news/filings
## source: finance.yahoo.com
Fri, 13 Jun 2014 11:44:07 GMT ~ VIROPRO INC Files SEC form 8-K, Change in Directors or Principal Officers
read full: http://biz.yahoo.com/e/140613/vpro8-k.html
*********************************************************
Tue, 03 Jun 2014 00:36:00 GMT ~ Court Recognizes Majority of Viropro Shareholders' Election of New Board of Directors
[PR Newswire] - SAN JOSE, Calif., June 2, 2014 /PRNewswire/ -- Viropro, Inc. (VPRO), a Nevada corporation that was formed to specialize in contract research, development and manufacturing of biotherapeutic proteins for the treatment of various diseases including cancer, diabetes, inflammation and hepatitis, today announced that it has a new Board of Directors as a result of an order of the Supreme Court of the State of New York in a challenge by a majority of the Viropro shareholders to the management of Viropro. On May 27, 2014 in a case styled Spring Hill Bioventures SDN BHD, derivatively and on behalf of Viropro, Inc., v. Cynthia Ekberg Tsai and Richard Serbin (Index No. 654167/2013), New York State Supreme Court Justice Eileen Bransten ordered that the will of the majority of Viropro shareholders set forth in a written consent dated March 27, 2014 be enforced and that Cynthia Ekberg Tsai and Richard Serbin, whose terms as directors had expired, be replaced by the following Board members: Bruce A. Cohen, Kenneth A. Sorensen and Michelle L. E. Peake. In addition, Justice Bransten ordered Cynthia Ekberg Tsai, the President and CEO of Viropro at the time of this court Order, to turn over all documents and incidents of control over Viropro, including all information about Viropro's accounts and access to them, to the new Board of Directors.
read full: http://finance.yahoo.com/news/court-recognizes-majority-viropro-shareholders-003600266.html
*********************************************************
Wed, 04 Dec 2013 15:47:53 GMT ~ VIROPRO INC Files SEC form 8-K, Entry into a Material Definitive Agreement
read full: http://biz.yahoo.com/e/131204/vpro8-k.html
*********************************************************
Fri, 08 Nov 2013 15:35:37 GMT ~ VIROPRO INC Files SEC form 8-K, Entry into a Material Definitive Agreement
read full: http://biz.yahoo.com/e/131108/vpro8-k.html
*********************************************************
Thu, 07 Nov 2013 15:03:36 GMT ~ VIROPRO INC Files SEC form 8-K, Other Events
read full: http://biz.yahoo.com/e/131107/vpro8-k.html
*********************************************************
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM